Dynamic contrast enhanced MRI with Gd-EOB-DTPA is a promising method for investigating liver function. However, many of the proposed procedures relies on such a high temporal resolution, and low spatial resolution, that the images are rendered unsuitable for radiographic reading. Here we have tested and validated a recently developed procedure using a whole-body pharmacokinetic model in a cohort of patients with chronic liver disease. Moreover we also show that the approach can separate advanced from mild fibrosis.
This abstract and the presentation materials are available to members only; a login is required.